Company Details
  • Taizhou Volsen Chemical Co., Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Mark: Americas , Asia , East Europe , Europe , North Europe , Other Markets , West Europe , Worldwide
  • Exporter:91% - 100%
  • Certs:GS, CE, ISO9001, ISO14000
  • Description:Dabrafenib Trade Name Tafinlar 1195768-06-9,Anti-cancer Dabrafenib Mesylate CAS 1195768-06-9,Dabrafenib Mesylate Selective BRAF V600E Inhibitor.
Taizhou Volsen Chemical Co., Ltd. Dabrafenib Trade Name Tafinlar 1195768-06-9,Anti-cancer Dabrafenib Mesylate CAS 1195768-06-9,Dabrafenib Mesylate Selective BRAF V600E Inhibitor.
Home > Products > Contract Manufacturing > Dabrafenib Mesylate(GSK2118436)1195768-06-9

Dabrafenib Mesylate(GSK2118436)1195768-06-9

Share to:  
    Unit Price: USD 1 / Kilogram
    Payment Type: T/T
    Incoterm: FOB
    Min. Order: 1 Kilogram
    Delivery Time: 15 Days

Basic Info

Model No.: 1195768-06-9

Additional Info

Packaging: AS REQUIRED

Productivity: KGS


Place of Origin: CHINA


Certificate: ISO

Product Description

In order to offer high quality Dabrafenib Mesylate CAS 1195768-06-9 to our customers. We processed Dabrafenib Mesylate CAS NO 1195768-06-9 adopt pure raw material and advanced equipment. Dabrafenib (GSK2118436) is a selective, orally bioavailable inhibitor of Mutant B-raf (BRAF) protein kinase with potential antineoplastic activity. It is also a drug the treatment of cancers associated with a mutated version of the gene BRAF. We can accept both customization and mass production. We can offer best service with reasonable price.

l Thera. Category:Anti- cancer

l Cas No.: 1195768-06-9

l Synonym:Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);GSK 2118436 methanesulfonate salt

l Molecular Formula:C24H24F3N5O5S3


l Molecular Weight:615.6680696

l Assay: ≥97.%

l Packing:Export worthy packing

l Material Safety Data Sheet:Available on request

l Usage: Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.

Related Intermediates :

1. CAS 630-22-8,2,2,2-Trimethylthioacetamide

Looking for ideal Dabrafenib Trade Name Tafinlar 1195768-06-9 Manufacturer & supplier ? We have a wide selection at great prices to help you get creative. All the Anti-cancer Dabrafenib Mesylate CAS 1195768-06-9 are quality guaranteed. We are China Origin Factory of Dabrafenib Mesylate Selective BRAF V600E Inhibitor.. If you have any question, please feel free to contact us.

Product Categories : Contract Manufacturing

Product Images
  • Dabrafenib Mesylate(GSK2118436)1195768-06-9
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2019 Taizhou Volsen Chemical Co., Ltd. All rights reserved.
Communicate with Supplier?Supplier
Amy Cheng Ms. Amy Cheng
What can I do for you?